Answer
In vitro, tucatinib inhibits HER2 and HER3 phosphorylation, reducing downstream cell signalling and proliferation and inducing death in HER2-driven tumour cells.
Sources for this answer
- TUKYSA 50 mg film-coated tabletPfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked